Health outcomes in economic evaluation: the QALY and utilities.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  British Medical Bulletin

• Publication date

  2010-12-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1093/bmb/ldq033PMID 21037243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Weighting Must Wait

  2012cited by this paper
• Management Essentials for Doctors: Audit

  2011cited by this paper
• Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

  2010cited by this paper
• Mepolizumab and exacerbations of refractory eosinophilic asthma.

  2009cited by this paper
• QALYs: the basics.

  2009cited by this paper
• Explicit incorporation of equity considerations into economic evaluation of public health interventions

  2009cited by this paper
• Health‐Related Quality‐of‐Life Evaluation of Crohn Disease Patients After Receiving Natalizumab Therapy

  2009cited by this paper
• Moving the QALY forward: rationale for change.

  2009cited by this paper
• Toward a consensus on the QALY.

  2009cited by this paper
• QALYs: some challenges.

  2009cited by this paper
• The use of QALYs in clinical and patient decision-making: issues and prospects.

  2009cited by this paper
• Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations.

  2009cited by this paper
• Retaining, and enhancing, the QALY.

  2009cited by this paper
• The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis

  2009cited by this paper
• Healthy-years equivalent: wounded but not yet dead

  2009cited by this paper
• Making Choices in Health: WHO Guide to Cost Effectiveness Analysis

  2008cited by this paper
• Measuring and Valuing Health Benefits for Economic Valuation

  2007cited by this paper
• Economic outcomes and levers: impacts for individuals and society

  2007cited by this paper
• Methods for the economic evaluation of health care programmes, 3rd ed

  2006cited by this paper
• The Elicitation of Distributional Judgements in the Context of Economic Evaluation

  2006cited by this paper
• Calculating QALYs, comparing QALY and DALY calculations.

  2006cited by this paper
• What value health?

  2005cited by this paper
• Healthy year equivalents versus quality-adjusted life years: the debate continues

  2005cited by this paper
• Making Choices in Health : WHO Guide to Cost Effectiveness Analysis, edited by T. Tan-Torres Edejer, R. Baltussen, T. Adam, R. Hutubessy, A. Acharya, D.B. Evans and C.J.L. Murray : book review

  2004cited by this paper
• Discounting health outcomes in economic evaluation: the ongoing debate.

  2004cited by this paper
• Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.

  2004cited by this paper
• Long-term urinary quality of life after permanent prostate brachytherapy.

  2003cited by this paper
• The Health Utilities Index (HUI®): concepts, measurement properties and applications

  2003cited by this paper
• Making Choices in Health: WHO Guide to Cost Effectiveness Analysis

  2003cited by this paper
• Not-only-a-title

  2003cited by this paper
• The estimation of a preference-based measure of health from the SF-36.

  2002cited by this paper
• Equity and the economic evaluation of healthcare.

  2001cited by this paper
• An Overview of the Normative Economics of the Health Sector

  2000cited by this paper
• Global burden of disease.

  1997cited by this paper
• Quality of life and pharmacoeconomics in clinical trials

  1996cited by this paper
• Quality of life and pharmacoeconomics in clinical trials

  1996cited by this paper
• Quantifying disability: data, methods and results.

  1994cited by this paper
• The morality of efficiency in health care--some uncomfortable implications.

  1992cited by this paper
• Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents

  1989cited by this paper
• A QALY is a QALY--or is it?

  1988cited by this paper
• A QALY is a QALY is a QALY -- Or is it?

  1988cited by this paper
• Methods for the economic evaluation of health care programmes

  1987cited by this paper

• First-line enfortumab vedotin-pembrolizumab versus nivolumab plus gemcitabine-cisplatin in metastatic urothelial cancer: a cost-effectiveness study.

  2026cites this paper
• Refined utilitarianism in practice: reinterpreting the ethical foundations of the NHS

  2026cites this paper
• Measuring the Impact of Common Prostate Cancer Survivorship Conditions with Health Utilities.

  2026cites this paper
• Surgical treatment of recurrent glioblastoma: a multicenter perspective from the Italian society of neurosurgery (SINch®) and a systematic review

  2026cites this paper
• Cost-effectiveness of targeted feedback interventions after depression screening in primary care: health economic evaluation of the GET.FEEDBACK.GP trial

  2026cites this paper
• Effect of a stepped-care trauma rehabilitation programme for migrants in Germany: the 'NAT counselling intervention' study protocol for a naturalistic parallel group trial with a regression discontinuity design for quasi-randomization.

  2026cites this paper
• Quality-Adjusted Life Year Gains After Total Hip and Knee Arthroplasty: A Review of Cost-Effectiveness Evidence and Policy Implications.

  2026cites this paper
• AI for screening in healthcare: promise and challenges.

  2026cites this paper
• SENSE-Cog Residential Care: piloting hearing and vision support for dementia in long-term care

  2026cites this paper
• Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis

  2026cites this paper
• Evaluating a transdisciplinary supportive care model for advanced liver disease: Results of the Liver Life pilot randomized controlled trial (RCT)

  2026cites this paper
• Calculating and comparing value in orthopaedic hip trauma: A systematic review.

  2026cites this paper
• Total hip arthroplasty restores population health-related quality of life norms

  2026cites this paper
• Early Support after Exposure to Trauma (EASE): protocol for a hybrid effectiveness-implementation trial of an internet-based intervention for PTSD prevention.

  2026cites this paper
• An economic analysis of Native CHOICES

  2025cites this paper
• Health Utility Values and Influencing Factors Among Pregnant and Postpartum Women in Rural Yunnan Province, China

  2025cites this paper
• Patient-level Value Analysis: A Model for Implementing the Concept of Value-based Healthcare Into Clinical Practice.

  2025cites this paper
• Effects of aquatic high-intensity interval training on patient-reported outcome measures and quality-adjusted life-years in adults with rheumatic and musculoskeletal diseases: a secondary analysis of the AquaHigh randomised controlled trial

  2025cites this paper
• Quantifying Cumulative Postoperative Disability after Lumbar Spine Surgery with Spline-Based Modified Integrated Health State.

  2025cites this paper
• SAGES 2025 guidelines for fluorescence image-guided gastrointestinal surgery using indocyanine green

  2025influential citation
• Cost-Effective Analysis of Ultrasound Evaluation for Hydronephrosis in Stage 3 and Stage 4 POP.

  2025cites this paper
• Cost–benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran

  2025cites this paper
• Outcomes and complications among nonagenarians undergoing cardiac surgery: A scoping review

  2025cites this paper
• Psychometric performance of EQ-5D-5L and SF-6Dv2 in cancer patients

  2025cites this paper
• Cost-Utility of Geriatric Assessment and Management in Older Adults With Cancer: Model-Based Economic Evaluation.

  2025cites this paper
• Measuring health-related quality of life of patients with metastatic colorectal cancer using the Jordanian EQ-5D-3L value set: a cross-sectional observational study

  2025cites this paper
• Adapted Safety Plans to Address Self-Harm and Suicide Behaviours in Autistic Adults: single arm feasibility trial and external pilot RCT.

  2025cites this paper
• The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study

  2025cites this paper
• Respiratory syncytial virus immunoprophylaxis: an underutilized preventive strategy in children with Down syndrome.

  2025cites this paper
• Use of Health State Utility Values in Cost-Utility Analyses of Selected Infectious Diseases in Aging Populations: A Systematic Review and Critical Appraisal.

  2025cites this paper
• The hidden economic burden of cancer caring

  2025cites this paper
• Health Utility Survival for Randomized Clinical Trials: Extensions and Statistical Properties

  2025cites this paper
• Impact of Workers' Compensation Benefits on Health-Related Quality of Life for Working Adults: A Burn Model System Investigation.

  2025cites this paper
• Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study

  2025cites this paper
• Health state utilities for Achondroplasia: a Time Trade-Off study.

  2025cites this paper
• Cost‐Utility of Fluticasone Propionate/Salmeterol and Fluticasone Propionate Monotherapy in Step‐Up Treatment of Childhood Asthma

  2025cites this paper
• A Person-centered eHealth Intervention for Patients with Common Mental Disorders: Cost-effectiveness Analysis within a Randomized Controlled Trial.

  2025cites this paper
• Quality‐Adjusted Time Without Symptoms of Disease or Toxicity (Q‐TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib

  2025cites this paper
• Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework

  2025cites this paper
• Association between healthcare resources, healthcare systems, and population health in European countries

  2025cites this paper
• Are Children's Self-Reports and Proxy-Reports of Health Utility Agreed? A School-Based Study in China using the EQ-5D-Y and CHU-9D

  2025cites this paper
• Did Economic Evaluations on Pharmaceuticals and Vaccination for COVID‐19 Maintain Adequate Reporting Quality? A Systematic Review and Quantitative Analysis

  2025cites this paper
• Disability-Related Loss in Lifespan and Specific Social Determinants of Health Among Middle-Aged and Older Adults with Disabilities: Evidence from China’s Aging Population

  2025cites this paper
• Cost-effectiveness analysis of robotic exoskeleton versus conventional physiotherapy for stroke rehabilitation in Singapore from a health system perspective

  2025cites this paper
• Cost-Effectiveness and the Distinction Between Quantitative and Qualitative Disability Discrimination

  2025cites this paper
• Aphasia-specific or generic outcomes? a comparison of two health-related quality of life instruments for economic evaluations of aphasia treatments

  2025cites this paper
• The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis.

  2025cites this paper
• Economic burden and cost-effectiveness of treatments for open tibia fractures in Malawi: Economic analysis of a multicentre prospective cohort study

  2025cites this paper
• Impact of Inactivated Influenza Vaccination on Health‐Related Quality of Life Among Japanese Healthcare Workers

  2025cites this paper
• Critical appraisal of an original research article

  2025cites this paper
• Comparing the measurement properties of the EQ-5D-Y-3L and EQ-5D-3L in a general population sample of adults.

  2025cites this paper
• Portuguese validation of the Italian BASIQ quality of life assessment battery and implications for health resource consumption.

  2025cites this paper
• Assessment of the added value of a tubeless pump: A time trade‐off (TTO) study for utility elicitation of insulin delivery systems in type 1 diabetes mellitus (T1D)

  2025cites this paper
• Subcutaneous immunotherapy-a wolf in sheep's clothing?

  2025cites this paper
• SAGES-AHPBA 2025 guideline for the surgical management of bile duct injury following cholecystectomy

  2025influential citation
• Impact of CAR T-cell therapy on Health Utilities of patients diagnosed with Diffuse Large B-cell Lymphoma in Canada.

  2025cites this paper
• Setting priorities for healthcare interventions in Indonesia: a comprehensive conceptual framework

  2025cites this paper
• QALY loss associated with unhealthy behaviors: evidence from a multi-center cross-sectional study in Iran

  2025cites this paper
• Cost-effectiveness of Zvandiri, a community-based support intervention to reduce virological failure in adolescents living with HIV in Zimbabwe: Results of a decision analytical model

  2025influential citation
• Soft-tissue quadriceps tendon autograft during primary anterior cruciate ligament reconstruction in Skeletally-immature patients vs. Hamstrings: A protocol for a multi-centre randomized controlled trial

  2025cites this paper
• The Recovering Quality of Life – Utility Index (ReQoL-UI): the Hong Kong valuation study

  2025cites this paper
• Assessment of cost-effectiveness threshold using a double-bounded dichotomous choice model

  2025cites this paper
• Comparing the measurement properties of the EQ-5D-Y-3L, EQ-5D-Y-5L and CHU9D in children and adolescents: a measurement property study

  2025cites this paper
• Innovations in heart failure management: The role of cutting-edge biomarkers and multi-omics integration

  2025cites this paper
• Assessment of willingness to pay for a quality-adjusted life year in the post COVID-19 pandemic era in Japan.

  2025cites this paper
• Evaluating the clinical and economic impact of ceramide-infused skin barriers in patients with Intestinal and urinary stomas: A systematic review and meta-analysis.

  2025cites this paper
• Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma

  2025influential citation
• Global Burden of Tracheal, Bronchus, and Lung Cancer in Adults Over 55 Years Old Based on Socio-demographic Status and Geographical and Gender Differences from 2010-2021

  2025cites this paper
• Cost-Effectiveness of Hearing Aids in South Korea: A Multistate Markov Model Analysis

  2025cites this paper
• How should medicines reimbursement work? The views of Spanish experts

  2025cites this paper
• Utility Values of Health Status in Gastric Cancer: A Systematic Review.

  2025cites this paper
• Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments

  2025cites this paper
• Global Trend of Breast Cancer Among Women Aged 55 and Older From 2010 to 2019: An Analysis by Socio-Demographic Index and Geographic Regions

  2025cites this paper
• Recovery trajectories after a serious injury or illness: a longitudinal evaluation of health-related quality of life in an Australian cohort

  2025cites this paper
• Preferences for health-related quality of life: do they vary by age? A systematic literature review on the EQ-5D measure

  2025cites this paper
• Health economic evaluation of Autism Adapted Safety Plans: findings on feasibility of tools from a pilot randomised controlled trial

  2025cites this paper
• Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

  2025cites this paper
• Impact of Choice of Tariff When Calculating Clinically Meaningful EQ‐5D Scores in Metabolic Dysfunction‐Associated Steatohepatitis

  2025cites this paper
• Validity and reliability of the Sanitation-related Quality of Life index (SanQoL-5) in six countries

  2025cites this paper
• The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review

  2025cites this paper
• Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents

  2025cites this paper
• A Multistate Markovian Model of the Economic Burden for Allergy Immunotherapy

  2025cites this paper
• Core outcomes for the evaluation of new healthcare programmes – a modified Delphi study

  2025cites this paper
• The association between myopia and health-related quality of life among Chinese children in primary and secondary school: A cross-sectional study

  2025cites this paper
• Att navigera i okända vatten med hjälp av hälsoekonomiska modeller

  2025cites this paper
• Translation, cultural adaptation, and content validation of the Hong Kong Chinese version of Self-completion Adult Social Care Outcomes Toolkit (ASCOT-SCT4) for care service users

  2025cites this paper
• Systematic Literature Review of Decision‐Analytic Modeling Studies on Nature‐Based Social Prescribing and Loneliness

  2025cites this paper
• Enhancing early detection and treatment of psychosis in Germany: a protocol for the health economic evaluation of an artificial intelligence-guided complex intervention

  2025cites this paper
• Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods

  2025cites this paper
• Impact of influenza-like illnesses on health state utility value among Japanese children and adults

  2025cites this paper
• Value-Based Care in Orthopaedic Surgery: Outcomes, Costing, and Policy Updates.

  2025cites this paper
• Are generic preference-based measures valid for use in informal carers? A psychometric investigation.

  2025cites this paper
• Psychometric properties of the ICECAP-SCM capability-wellbeing measure in specialist palliative care units in Austria

  2025cites this paper
• The value of health and well-being from a societal perspective: A willingness to pay experiment in the Netherlands.

  2025cites this paper
• Associations between clinical benefits of cancer drugs and incremental quality-adjusted life years used in reimbursement decisions in Australia, Canada, England and China: an observational study

  2025cites this paper
• Calculating Value in Hand and Wrist Care: A Systematic Review on the Current Literature

  2025cites this paper
• Health state utility values and associated complication-related difference in community-based adults with type 2 diabetes in Nanjing China: a cross-sectional study

  2025cites this paper
• How do different health states impact preferences for social care related quality of life: An exploration of EQ-5D-5L and ASCOT using a vignette approach.

  2025cites this paper
• Cost-Effective Strategies for Infectious Diseases: A Multi-Objective Framework with an Interactive Dashboard

  2025cites this paper
• A scoping review on the methods used to assess health-related quality of life and disability burden in evaluations of road safety interventions.

  2025cites this paper